BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1600527)

  • 1. Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified?
    Miller WR; Scott WN; Harris WH; Wang D
    Cancer Detect Prev; 1992; 16(2):99-106. PubMed ID: 1600527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
    Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
    Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
    Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
    Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The correlation between morphology, electrolytic content and risk factors in breast cysts].
    Grosso A; Gardelli G; Mei F; Battista G; Boriani F; Ghigi G; Motta R; Marino SA; Burlizzi S; Corinaldesi A
    Radiol Med; 1996 Mar; 91(3):194-7. PubMed ID: 8628929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids status in human breast cyst fluids.
    Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
    Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.
    Lai LC; Siraj AK; Erbas H; Lennard TW
    Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Categorization of cysts and steroid levels in breast cyst fluid.
    Angeli A; Caraci P; Puligheddu B; Torta M; Orlandi F; Dogliotti L
    Cancer Detect Prev; 1992; 16(1):53-6. PubMed ID: 1551138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of breast cyst subpopulations: biochemical and morphological features.
    Zanardi S; Valenti G; Torrisi R; Maisto L; Nicolò G; Barreca A; Minuto F; Boccardo F
    Cancer Detect Prev; 1991; 15(4):273-6. PubMed ID: 1838953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of breast cysts and breast cancer.
    Devitt JE
    Can J Surg; 1988 Sep; 31(5):356-8. PubMed ID: 3416250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration.
    Athanassiadou PP; Veneti SZ; Kyrkou KA; Intzes KS; Mouzaka LI; Papadimitriou GK
    Cancer Detect Prev; 1992; 16(2):113-8. PubMed ID: 1600520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of human breast cysts according to electrolyte and androgen conjugate composition.
    Miller WR; Dixon JM; Scott WN; Forrest AP
    Clin Oncol; 1983 Sep; 9(3):227-32. PubMed ID: 6225590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of dehydroepiandrosterone sulphate by breast cysts: possible role in the development of breast cancer.
    Lai LC
    Cancer Detect Prev; 1995; 19(5):441-5. PubMed ID: 7585731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytologic examination.
    Vizoso F; Fueyo A; Allende MT; Fernández J; García-Morán M; Ruibal A
    Eur J Surg Oncol; 1990 Jun; 16(3):209-14. PubMed ID: 2140797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory substances in human breast cyst fluid.
    Lai LC; Chan CT; Cornell C; Lennard TW
    Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and estrogen in breast cyst fluids.
    Burch JB; Walling M; Rush A; Hennesey M; Craven W; Finlayson C; Anderson BO; Cosma G; Wells RL
    Breast Cancer Res Treat; 2007 Jul; 103(3):331-41. PubMed ID: 17061046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor levels in human breast cyst fluid.
    Battaglia F; Rossi S; Scambia G; Lanzone A; Benedetti-Panici P; Ferrandina G; Lombardi CP; Bellantone R; Crucitti F; Mancuso S
    Anticancer Res; 1989; 9(6):1661-3. PubMed ID: 2627118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor profiles in breast cyst fluid identify women with increased breast cancer risk.
    Hess JC; Sedghinasab M; Moe RE; Pearce LA; Tapper D
    Am J Surg; 1994 May; 167(5):523-30. PubMed ID: 8185042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.